Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Allarity Therapeutics, Inc. (ALLR)
NASDAQ:ALLR
Holding ALLR?
Track your performance easily
ALLR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.90 - $287.78
Previous CloseN/A
Volume542.33K
Average Volume (3M)2.31M
Market Cap
$6.03M
Enterprise Value-$13.80M
Total Cash (Recent Filing)$1.52M
Total Debt (Recent Filing)$341.00K
Price to Earnings (P/E)―
Beta1.66
Next Earnings
May 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-883.45
Shares Outstanding4,433,587
10 Day Avg. Volume2,383,021
30 Day Avg. Volume2,305,455
Standard Deviation0.30
R-Squared0.00104
Alpha-0.29
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market Cap-2.29
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda1.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Allarity Therapeutics, Inc. News
PremiumCompany Announcements
Allarity Therapeutics Strengthens Leadership for Cancer ProgramsOwnership Overview
2.67% Insiders
―
Mutual Funds
― Other Institutional Investors
97.33% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ALLR FAQ
What was Allarity Therapeutics, Inc.’s price range in the past 12 months?
Allarity Therapeutics, Inc. lowest stock price was $0.90 and its highest was $287.78 in the past 12 months.
What is Allarity Therapeutics, Inc.’s market cap?
Allarity Therapeutics, Inc.’s market cap is $6.03M.
When is Allarity Therapeutics, Inc.’s upcoming earnings report date?
Allarity Therapeutics, Inc.’s upcoming earnings report date is May 19, 2025 which is in 108 days.
How were Allarity Therapeutics, Inc.’s earnings last quarter?
Allarity Therapeutics, Inc. released its earnings results on Nov 14, 2024. The company reported -$7.71 earnings per share for the quarter, missing the consensus estimate of N/A by -$7.71.
Is Allarity Therapeutics, Inc. overvalued?
According to Wall Street analysts Allarity Therapeutics, Inc.’s price is currently Overvalued.
Does Allarity Therapeutics, Inc. pay dividends?
Allarity Therapeutics, Inc. does not currently pay dividends.
What is Allarity Therapeutics, Inc.’s EPS estimate?
Allarity Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Allarity Therapeutics, Inc. have?
Allarity Therapeutics, Inc. has 4,433,587 shares outstanding.
What happened to Allarity Therapeutics, Inc.’s price movement after its last earnings report?
Allarity Therapeutics, Inc. reported an EPS of -$7.71 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.759%.
Which hedge fund is a major shareholder of Allarity Therapeutics, Inc.?
Currently, no hedge funds are holding shares in ALLR
---
Company Description
Allarity Therapeutics, Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improve clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra.
---
Technical Analysis
Karyopharm Therapeutics
―
Sorrento Therapeutics
―
Marinus
―
Anavex Life Sciences
―
Arvinas Holding Company
―
---